Furthermore, cellular ADAM17 activity was significantly elevated in cultures treated with ischemic stroke serum relative to those treated with serum from control groups (Fig. 4D), and supernatants recovered from cultures treated with ischemic stroke serum contained significantly higher concentrations of monocyte-derived sCD163 (Fig. 4E). Here, ADAM17 is linked to ischemic stroke.